Drug
ado-trastuzumab emtansine
Marketed as KADCYLA.
Generic name
ado-trastuzumab emtansine
Brand names
KADCYLA
First FDA approval
2013-02-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA125427 | KADCYLA | 2013-02-22 | GENENTECH |
Manufacturers
GENENTECH
Frequently asked questions
When was ado-trastuzumab emtansine FDA approved?
Earliest FDA approval on record: 2013-02-22.
What brand names are sold as ado-trastuzumab emtansine?
KADCYLA.
Sources
Appeal a ado-trastuzumab emtansine denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com